Home / Companies / Janux Therapeutics, Inc. / 26 Jun 2024
Janux Therapeutics, Inc.: meeting of 26 Jun 2024
Votes reported on Form N-PX, item by item
93 Form N-PX filers reported votes at the Janux Therapeutics, Inc. meeting of 26 Jun 2024. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 76.6% of reported votes for; 61 filers withheld from or voted against at least one nominee.
519 vote records from 93 filers. 5 of the 93 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
173 vote records from 93 filers. 1 of the 93 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | Abstain or withhold * | For |
| State Street and SPDR | For | For |
| American Century | For | For |
| Invesco | For | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| ProShares and ProFunds | For | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| Jackson National funds | Abstain or withhold * | For |
| Northern Trust and FlexShares | For | For |
| SEI | For | For |
| T. Rowe Price | For | For |
| Lincoln Financial | For | For |
| Voya | Abstain or withhold * | For |
| Nationwide | For | For |
| Victory Capital | For | For |
| Brighthouse Funds | For | For |
| Guggenheim and Rydex | For | For |
| BNY Mellon | For | For |
| Principal | For | For |
| Pacific Life funds | For | For |
| Global X | For | For |
| DWS | For | For |
| Allspring | For | For |
| Macquarie and Delaware Funds | For | For |
| Janus Henderson | For | For |
| Lord Abbett | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Janux Therapeutics, Inc. meeting?
93 Form N-PX filers reported votes at the meeting of 26 Jun 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Janux Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Janux Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Janux Therapeutics, Inc. with a meeting date within three days of 26 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.